SK, A., AA, A., SW, K., & VM, M. (2022). Considerations for Inotrope and Vasopressor Use in Critically Ill Patients With Pulmonary Arterial Hypertension. Journal of cardiovascular pharmacology, 79(1), e11. https://doi.org/10.1097/FJC.0000000000001155
Chicago Style (17th ed.) CitationSK, Adie, Abdul-Aziz AA, Ketcham SW, and Moles VM. "Considerations for Inotrope and Vasopressor Use in Critically Ill Patients With Pulmonary Arterial Hypertension." Journal of Cardiovascular Pharmacology 79, no. 1 (2022): e11. https://doi.org/10.1097/FJC.0000000000001155.
MLA (9th ed.) CitationSK, Adie, et al. "Considerations for Inotrope and Vasopressor Use in Critically Ill Patients With Pulmonary Arterial Hypertension." Journal of Cardiovascular Pharmacology, vol. 79, no. 1, 2022, p. e11, https://doi.org/10.1097/FJC.0000000000001155.